v3.25.2
Stockholders' Equity (Details)
 3 Months Ended 12 Months Ended
Jun. 17, 2024
USD ($)
shares
Apr. 17, 2024
USD ($)
shares
Sep. 13, 2023
USD ($)
shares
Aug. 14, 2023
USD ($)
shares
Feb. 28, 2023
shares
Jan. 31, 2023
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Jan. 04, 2024
$ / shares
shares
Dec. 28, 2023
shares
Jul. 05, 2023
$ / shares
Dec. 31, 2022
$ / shares
shares
Stockholders’ Equity [Line Items]                            
Common stock, shares authorized (in Shares)             3,254,475,740   3,254,475,740 500,000,000        
Common stock, voting rights             Common Stock are entitled to vote on a 1 share/1 vote basis   common stock are entitled to vote on a 1 share/1 vote basis          
Warrants exercise price (in Dollars per share) | $ / shares             $ 0.033   $ 0.033          
Fair value of warrants issuance | $   $ 35,814                        
Aggregate fair value | $ $ 170,920 $ 35,814                        
Consecutive trading days             20 days              
Exercise price of the warrants             300.00%   300.00%          
Trading day             20 days              
Trading period equals or exceeds amount | $             $ 500,000   $ 500,000          
Per share (in Dollars per share) | $ / shares             $ 0.001   $ 0.001          
Options outstanding (in Shares)                 184,264,323 163,142,084       163,142,084
Increase in value additional share-based compensation expense | $             $ 4,261,809   $ 4,261,809          
Increase additional share-based compensation expense | $             23,193 $ 537,197 2,246,033 $ 2,253,793        
Share-base compensation | $             $ 23,193 537,197 $ 2,246,033 $ 2,253,793        
Options to purchase common shares (in Shares)                 21,122,239        
Share based compensation | $                 $ 2,246,033 $ 2,253,793        
Common stock, par value (in Dollars per share) | $ / shares             $ 0.0001   $ 0.0001 $ 0.0001        
Common stock, outstanding (in Shares)             956,997,116   956,997,116 495,454,546        
Common stock, issued (in Shares)             956,997,116   956,997,116 495,454,546        
Shares of common stock were returned (in Shares)         330,952,906                  
Private placement | $     $ 200,000 $ 5,025,000         $ 5,225,000        
Share exchange totaled | $                 $ 571,796          
Preferred stock, shares authorized (in Shares)             12,500,000   12,500,000 12,500,000        
Preferred stock, par value (in Dollars per share) | $ / shares             $ 0.0001   $ 0.0001 $ 0.0001        
Preferred stock, shares outstanding (in Shares)             5,847,937   5,847,937 10,463,363        
closing stock price per share (in Dollars per share) | $ / shares                 $ 0.01 $ 0.01       $ 0
Fair value of stock option | $                 $ 1,612,841 $ 1,420,603        
Share based compensation relating to research and development expenses (in Dollars per share) | $ / shares                 $ 0.01 $ 0.03        
Unrecognized compensation cost | $                 $ 39,171          
Weighted average period                 6 months          
Warrant [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)       489,834,426                    
Warrants to purchase common shares (in Shares)                 510,794,865          
Warrants expired (in Shares)                 20,960,439          
closing stock price per share (in Dollars per share) | $ / shares                 $ 0.01 $ 0.01       $ 0
Measurement Input, Share Price [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value                 0.0288          
Board of Directors Chairman [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)   10,454,500                        
Measurement Input, Expected Term [Member]                            
Stockholders’ Equity [Line Items]                            
Warrant expected life 5 years 5 years             5 years          
Measurement Input, Price Volatility [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value 76.58 77.1             78.87          
Measurement Input, Risk Free Interest Rate [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value 4.3 4.62             4.36          
Measurement Input, Expected Dividend Rate [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value 0 0             0          
Measurement Input, Share Price [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value 0.01 0.01                        
Measurement Input, Exercise Price [Member]                            
Stockholders’ Equity [Line Items]                            
Fair value 0.0037 0.033             0.0037          
General and Administrative Expenses [Member]                            
Stockholders’ Equity [Line Items]                            
Share based compensation | $ $ 170,920           $ 23,193 382,074 $ 1,673,270 $ 1,612,173        
Research and Development Expenses [Member]                            
Stockholders’ Equity [Line Items]                            
Share based compensation | $             0 155,123 572,763 641,620        
Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Increase additional share-based compensation expense | $                    
Common stock, par value (in Dollars per share) | $ / shares                         $ 0.0001  
Private Placement, shares (in Shares) [1]                   330,952,906        
Converted shares (in Shares) [1]                 461,542,570          
Common Stock [Member] | Board of Directors Chairman [Member]                            
Stockholders’ Equity [Line Items]                            
Options to purchase common shares (in Shares) 21,122,239                          
Equity Incentive Plan [Member]                            
Stockholders’ Equity [Line Items]                            
Options outstanding (in Shares)             163,142,084   163,142,084          
Increase additional share-based compensation expense | $             $ 1,420,603   $ 1,420,603          
Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)                 18,181,817          
Private Placement, shares (in Shares)           330,952,906                
Common shares issuable per share converted (in Shares)             100   100          
Series A Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, shares authorized (in Shares)                 12,500,000          
Preferred stock, par value (in Dollars per share) | $ / shares                 $ 0.0001       $ 0.0001  
Preferred stock, shares outstanding (in Shares)                 5,847,937          
Convertible into conversion price (in Dollars per share) | $ / shares                 $ 0.011          
Series A Preferred Stock [Member] | Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Increase additional share-based compensation expense | $                    
Private Placement, shares (in Shares) [1]                          
Converted shares (in Shares) [1]                 (4,615,426)          
Convertible Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Preferred stock, par value (in Dollars per share) | $ / shares                 $ 1.1          
Minimum [Member] | Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock, shares authorized (in Shares)                     500,000,000 500,000,000    
Maximum [Member] | Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock, shares authorized (in Shares)                     3,254,475,740 3,254,475,740    
Private Placement [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)     18,181,817 456,818,176                    
Private placement | $                 $ 5,225,000          
Private Placement [Member] | Warrant [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)       456,818,176                    
Private Placement [Member] | Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Private Placement, shares (in Shares)                 186,363,631          
Private Placement [Member] | Series A Preferred Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Private Placement, shares (in Shares)                 2,886,364          
Private Dror Shareholders [Member]                            
Stockholders’ Equity [Line Items]                            
Number of warrants issued (in Shares)       489,834,426                    
Private Dror [Member] | Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock, par value (in Dollars per share) | $ / shares                     $ 0.0001      
[1] The number shares of Common and Preferred A Stock outstanding were retroactively adjusted as a result of the Share Exchange. See Note 1